Billiontoone (NASDAQ:BLLN) Sees Large Volume Increase – Here’s Why

Billiontoone, Inc. (NASDAQ:BLLN) shares saw unusually-high trading volume on Tuesday . Approximately 938,737 shares traded hands during trading, an increase of 194% from the previous session’s volume of 318,964 shares.The stock last traded at $76.9530 and had previously closed at $72.12.

Billiontoone News Summary

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q1 results materially beat expectations — EPS $0.34 vs. consensus $0.01 and revenue $108.4M vs. $95.8M, an 83.8% year‑over‑year revenue gain. This is the primary catalyst for the stock rally. MarketBeat Q1 Report
• Positive Sentiment: Management raised FY2026 revenue guidance to $450M–$465M (above the prior consensus ~$437M), which supports upside to estimates and valuation. Press Release
• Positive Sentiment: JPMorgan upgraded/raised its price target to $125 with an “Overweight” rating, signaling institutional support and implying meaningful upside from current levels. TickerReport: JPMorgan
• Neutral Sentiment: BTIG trimmed its price target from $140 to $130 but kept a “Buy” rating — a modest calibration rather than a negative change in stance. TickerReport: BTIG
• Neutral Sentiment: Company materials and the earnings call/slides are available for deeper diligence (useful for modeling guidance and margin trajectory). Press Release / Slides Conference Call
• Neutral Sentiment: Analyst and media writeups (Zacks, Yahoo transcript, SFGate snapshot) provide context on unit trends, margins and model assumptions — useful but largely descriptive of the beat and guidance. Zacks Yahoo Transcript SFGate

Wall Street Analysts Forecast Growth

BLLN has been the subject of several recent research reports. Wells Fargo & Company reduced their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a report on Thursday, March 5th. JPMorgan Chase & Co. increased their target price on shares of Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Thursday. Weiss Ratings restated a “sell (d)” rating on shares of Billiontoone in a report on Friday, May 1st. BTIG Research dropped their price target on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Six equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $122.43.

Billiontoone Price Performance

The firm’s 50-day moving average price is $77.96. The company has a current ratio of 11.69, a quick ratio of 11.32 and a debt-to-equity ratio of 0.12.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to the consensus estimate of $95.81 million. Billiontoone’s revenue for the quarter was up 83.8% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.39) earnings per share. On average, sell-side analysts predict that Billiontoone, Inc. will post 0.42 EPS for the current fiscal year.

Hedge Funds Weigh In On Billiontoone

Several large investors have recently modified their holdings of BLLN. Adams Street Partners LLC bought a new position in Billiontoone during the fourth quarter worth about $140,063,000. Baillie Gifford & Co. bought a new position in Billiontoone during the fourth quarter worth about $103,786,000. Price T Rowe Associates Inc. MD bought a new position in Billiontoone during the fourth quarter worth about $39,717,000. JPMorgan Chase & Co. bought a new position in Billiontoone during the fourth quarter worth about $32,078,000. Finally, Wasatch Advisors LP bought a new position in Billiontoone during the first quarter worth about $29,179,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.